Recent trends in product development and regulatory issues on impurities in active pharmaceutical ingredient (API) and drug products. Part 1: Predicting degradation related impurities and impurity considerations for pharmaceutical dosage forms

AAPS PharmSciTech. 2014 Feb;15(1):198-212. doi: 10.1208/s12249-013-0047-x. Epub 2013 Nov 27.
No abstract available

MeSH terms

  • Dosage Forms*
  • Drug Contamination*
  • Drug Discovery / methods*

Substances

  • Dosage Forms